
Epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review.
http://www.sciencedaily.com/releases/2015/09/150915090415.htm
Epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review.
http://www.sciencedaily.com/releases/2015/09/150915090415.htm